Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
醫療保健領域超賣次數最多的股票爲買入被低估的公司提供了機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI 是一種動量指標，它比較股票在價格上漲的日子和價格下跌的日子的走勢。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據，當相對強弱指數低於30時，資產通常被視爲超賣。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是該行業主要超賣參與者的最新名單，RSI接近或低於30。
Molecular Templates, Inc. (NASDAQ:MTEM)
分子模板有限公司（納斯達克股票代碼：MTEM）
- On March 4, Molecular Templates issued an update on its programs. The company's stock fell around 32% over the past five days and has a 52-week low of $2.00 .
- RSI Value: 29.73
- MTEM Price Action: Shares of Molecular Templates fell 24.7% to close at $2.07 on Monday.
- 3月4日，分子模板發佈了其程序的最新消息。該公司的股票在過去五天中下跌了約32％，並且 52 周低點爲 2.00 美元 。
- RSI 值：29.73
- MTEM價格走勢：週一，分子模板股價下跌24.7％，收於2.07美元。
Fractyl Health, Inc. (NASDAQ:GUTS)
Fractyl Health, Inc.（納斯達克股票代碼：GUTS）
- On March 12, Fractyl Health released new preclinical findings for the first clinical candidate in its Rejuva pancreatic gene therapy platform. The company's stock fell around 31% over the past five days. It has a 52-week low of $5.92.
- RSI Value: 26.30
- GUTS Price Action: Shares of Fractyl Health fell 1.6% to close at $6.25 on Monday.
- 3月12日，Fractyl Health發佈了其Rejuva胰腺基因治療平台中首個臨床候選藥物的新臨床前發現。該公司的股票在過去五天中下跌了約31％。它 創下 52 周低點 爲 5.92 美元。
- RSI 值：26.30
- GUTS價格走勢：週一，Fractyl Health的股價下跌1.6％，收於6.25美元。
Inspire Veterinary Partners, Inc. (NASDAQ:IVP)
Inspire 獸醫合作伙伴有限公司（納斯達克股票代碼：IVP）
- On Jan. 5, Inspire Veterinary Partners filed a prospectus related to up to a $5 million public offering. The company's stock fell around 65% over the past month and has a 52-week low of $0.0380.
- RSI Value: 27.91
- IVP Price Action: Shares of Inspire Veterinary Partners fell 8.8% to close at $0.0456 on Monday.
- 1月5日，Inspire Veterinary Partners提交了一份與高達500萬美元的公開募股相關的招股說明書。該公司的股票在過去一個月中下跌了約65％，爲期52周 最低價爲0.0380美元。
- RSI 值：27.91
- IVP價格走勢：週一，Inspire Veterinary Partners的股價下跌8.8％，收於0.0456美元。
Outset Medical, Inc. (NASDAQ:OM)
Outset Medical, Inc.（納斯達克股票代碼：OM）
- On March 13, Outset Medical announced the appointment of medical technology veteran Brent D. Lang to its board of directors. The company's shares lost around 26% over the past five days. The company's 52-week low is $1.9750.
- RSI Value: 25.57
- OM Price Action: Shares of Outset Medical fell 7.8% to close at $2.00 on Monday.
- 3月13日，Outset Medical宣佈任命醫療技術資深人士布倫特·朗爲董事會成員。該公司的股價在過去五天中下跌了約26％。該公司的52周低點爲1.9750美元。
- RSI 值：25.57
- OM價格走勢：週一，Outset Medical的股價下跌7.8％，收於2.00美元。
Pacific Biosciences of California, Inc. (NASDAQ:PACB)
加州太平洋生物科學有限公司（納斯達克股票代碼：PACB）
- On Feb. 15, Pacific Biosciences posted a narrower-than-expected quarterly loss. "Our team successfully executed its goals in 2023 and launched PacBio on a trajectory this company has never seen before," said Christian Henry, President and CEO of PacBio. "We continue to build solutions across the workflow, allowing our customers to further scale on HiFi, and we are encouraged to see how researchers are already making discoveries and shifting paradigms with the power and economics of Revio and the extraordinary accuracy of Onso." The company's shares fell around 31% over the past month. The company has a 52-week low of $3.63.
- RSI Value: 29.10
- PACB Price Action: Shares of Pacific Biosciences of California fell 3.2% to close at $3.67 on Monday.
- 2月15日，太平洋生物科學公佈的季度虧損低於預期。PacBio總裁兼首席執行官克里斯蒂安·亨利表示：“我們的團隊在2023年成功實現了目標，並以該公司從未見過的軌跡啓動了PacBio。”“我們將繼續在整個工作流程中構建解決方案，使我們的客戶能夠進一步擴展HiFi的規模，看到研究人員如何利用Revio的力量和經濟性以及Onso的非凡準確性進行發現並改變範式，我們感到鼓舞。”該公司的股價在過去一個月中下跌了約31％。該公司 創下 52 周低點 爲3.63美元。
- RSI 值：29.10
- PACB價格走勢：週一，加州太平洋生物科學公司股價下跌3.2％，收於3.67美元。
Read More: Core & Main, Caleres And 3 Stocks To Watch Heading Into Tuesday
閱讀更多： Core & Main、Caleres和三隻股票在週二值得關注
譯文內容由第三人軟體翻譯。